HeartSciences Inc.
HSCS
$3.46
$0.113.28%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 14.70K | 18.60K | 18.60K | 18.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 14.70K | 18.60K | 18.60K | 18.60K |
| Cost of Revenue | 0.00 | 4.60K | 6.10K | 6.10K | 6.10K |
| Gross Profit | 0.00 | 10.10K | 12.50K | 12.50K | 12.50K |
| SG&A Expenses | 3.81M | 3.50M | 3.53M | 3.44M | 3.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.31M | 7.48M | 7.07M | 6.32M | 6.04M |
| Operating Income | -8.31M | -7.47M | -7.05M | -6.31M | -6.02M |
| Income Before Tax | -8.52M | -7.62M | -7.29M | -6.61M | -6.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.52 | -7.62 | -7.29 | -6.61 | -6.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.52M | -7.62M | -7.29M | -6.61M | -6.39M |
| EBIT | -8.31M | -7.47M | -7.05M | -6.31M | -6.02M |
| EBITDA | -8.27M | -7.43M | -7.02M | -6.28M | -6.00M |
| EPS Basic | -10.30 | -10.74 | -24.39 | -34.98 | -49.01 |
| Normalized Basic EPS | -6.44 | -6.71 | -15.24 | -21.86 | -30.63 |
| EPS Diluted | -10.30 | -10.74 | -24.39 | -34.98 | -49.01 |
| Normalized Diluted EPS | -6.44 | -6.71 | -15.24 | -21.86 | -30.63 |
| Average Basic Shares Outstanding | 3.34M | 2.90M | 2.09M | 1.41M | 856.70K |
| Average Diluted Shares Outstanding | 3.34M | 2.90M | 2.09M | 1.41M | 856.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |